AseBio BioSpain 2025Opportunity Health SL wins start-up pitch contestOut of 43 pitches, the founders of Spanish Opportunity Health S.L. delivered the best presentation for a new life sciences product: a choking device that can potentially be used by anyone in emergency … more ➔
AseBioBioSpain 2025 Panel discussion: what drives US investments?Alongside a start-up pitch featuring 45 international participants, the second day of BioSpain 2025 (7–9 October 2025, Barcelona) offered biotech start-ups a panel discussion with prominent US investors, … more ➔
https://www.chimia.ch/chimia/article/view/2025_292BiomanufacturingBiomanufacturing in SwitzerlandSwitzerland is a key hub for biomanufacturing, with immunological products like antibodies and vaccines making up 18.5% of 2024 exports. Swiss companies drive biotech innovation and biocatalysis across … more ➔
AseBioBioSpain 2025Spain again tops Europe in clinical trialsSpain has once again secured the top position in Europe for clinical trials. According to various Clinical Research Organisations at BioSpain 2025 (7–9 October, Barcelona), this is largely due to the … more ➔
Kinga Lubowiecka/ EMBLResearch InfrastructureEMBL and BIS: Advancing Biological ImagingThe EMBL Imaging Centre has received €7 million in support from Boehringer Ingelheim Stiftung to further advance its cutting-edge imaging technologies. more ➔
SPRINDDeeptech bioeconomyIt is time to rethink biotech scalingBiomanufacturing promises domestic, sustainable, sovereign and resilient production. Capacities are trapped in outdated scale-up processes. SPRIND urges investment and disruptive innovation to propel … more ➔
Chemspec Europe 2025Fine and speciality chemicals industry keeps its coolResilience and quality connections define Chemspec Europe 2025. more ➔
MedicalWorks from Adobe Stockin vitro fertilizationEight healthy children born with DNA from three peopleA landmark study in the UK shows that mitochondrial replacement therapy can prevent babies from inheriting diseases caused by mutant mitochondria. more ➔
Axxam S.p.APreclinical target validationClinical data meet preclinical validation: Axxam´s partnership with Molecular HealthThat deserves a closer look: The recently announced partnership between Axxam S.p.A., a leading provider of integrated early discovery services, and Molecular Health GmbH, a pioneer in AI-powered data … more ➔
ASEBIOASEBIOSpain’s biotech: growth, impact and global roleSpain’s biotech sector drives innovation, economic growth, and scientific excellence. With strong R&D investment, global research impact, and a leading role in gender equality, it’s a key player … more ➔
AseBio 
AseBio
https://www.chimia.ch/chimia/article/view/2025_292
AseBio
Kinga Lubowiecka/ EMBL
SPRIND
MedicalWorks from Adobe Stock
Axxam S.p.A
ASEBIO